Category - Executive Moves

Executive Moves

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

NeuroOne Medical Technologies (OTCQB:NMTC) appointed neural engineer, Camilo Andres Diaz-Botia, as director of electrode development. Dr. Diaz-Botia previously led the microfabrication process engineering team at...

June 17, 2020

Executive Moves

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed industry veteran, Dr. Peter Wijngaard, to its board of directors. “Dr. Wijngaard provided invaluable guidance to Hepion’s management team during our earlier work on...

June 10, 2020

Executive Moves

AMAG Pharma appoints Scott Myers as president and CEO

AMAG Pharmaceuticals (NASDAQ:AMAG) appointed Scott Myers as its president and CEO, and a member of the board, effective immediately. Mr. Myers was most recently chairman and CEO of Rainier Therapeutics. He replaces...

April 28, 2020

Executive Moves

PharmaJet appoints Chris Cappello as president and CEO

Closely-held PharmaJet appointed Chris Cappello as its president and CEO, replacing Ron Lowy, who was appointed as executive chairman. “In the 10 years that [Mr.Cappello] has worked for PharmaJet, he has shown the...

April 28, 2020

Executive Moves

TerrAscend appoints Jason Ackerman as permanent CEO; CFO to step down

TerrAscend (OTCQX:TRSSF) appointed Jason Ackerman as CEO and reported that its CFO, Adam Kozak, will step down as the company relocates its financial operations from Toronto to New York City. Mr. Ackerman joined...

April 14, 2020

Executive Moves

Five Prime Therapeutics appoints industry leader, Tom Civik, as CEO

Five Prime Therapeutics (NASDAQ:FPRX) appointed Tom Civik as president, CEO and a director. William Ringo, who served as Five Prime’s chairman and interim CEO since September 2019, will step down as CEO and continue as...

April 14, 2020

Executive Moves

Dr. Anjay Rastogi joins XORTX Therapeutics CAB

Dr. Anjay Rastogi has joined the clinical advisory board of XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF), bringing professional experience as a thought leader, combined with clinical experience treating patients with...

March 26, 2020

Executive Moves

Akcea names Damien Devitt as CEO

Damien Devitt, who has been interim CEO of Akcea Therapeutics (NASDAQ:AKCA) since September 2019, has been promoted to CEO, effective immediately, and will continue to serve as a member of Akcea’s board. “With his...

March 24, 2020

Executive Moves

iBio appoints accomplished life sciences executive, Thomas Isett, as co-chairman and CEO

iBio (NYSE AMERICAN:IBIO) appointed Thomas Isett, a current iBio board member, as its co-chairman and CEO. Mr. Isett succeeds Robert Kay, who has retired from the role of CEO, but will remain as co-chairman and a member...

March 12, 2020

Executive Moves

Covetrus names Benjamin Wolin as CEO

Benjamin Wolin, who has been acting CEO of Covetrus (NASDAQ:CVET) since October 2019, has been promoted to president and CEO, effective immediately. Covetrus was formed in February 2019 as the result of a spin out of...

March 4, 2020

Category - Executive Moves

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

AMAG Pharma appoints Scott Myers as president and CEO

PharmaJet appoints Chris Cappello as president and CEO

TerrAscend appoints Jason Ackerman as permanent CEO; CFO to step down

Five Prime Therapeutics appoints industry leader, Tom Civik, as CEO

Dr. Anjay Rastogi joins XORTX Therapeutics CAB

Akcea names Damien Devitt as CEO

iBio appoints accomplished life sciences executive, Thomas Isett, as co-chairman and CEO

Covetrus names Benjamin Wolin as CEO

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter